HIV-1 Antigen Test

If you have been exposed to HIV, the difference between catching the infection at two weeks versus two months can shape your entire treatment trajectory. People diagnosed and treated during the earliest phase of infection tend to preserve more of their immune function and may reduce the long-term size of the viral reservoir, the hidden pool of virus that embeds itself in long-lived cells. The HIV-1 antigen test exists to close that gap.

HIV-1 antigen refers to a specific viral protein called p24, the main structural protein that forms the inner shell of the virus. When HIV is actively replicating in your body, p24 floods into your bloodstream. It becomes detectable in blood roughly one to three weeks before your immune system produces enough antibodies to trigger a positive result on older antibody-only tests. That early window is exactly where this test earns its value.

What This Test Actually Measures

Most modern HIV screening tests are called fourth-generation or combination antigen/antibody (Ag/Ab) tests. They look for two things at once: p24 antigen (a piece of the virus itself) and antibodies your immune system makes in response to the virus. When your result is reported, it typically comes back as reactive (meaning something was detected) or non-reactive (nothing detected). If the test is reactive, your lab will run additional confirmatory tests to determine whether you truly have HIV and, if so, which type.

The p24 component is what makes these tests "fourth generation." Earlier test generations looked only for antibodies, which can take weeks or even months to reach detectable levels. By also detecting p24 antigen, the test shrinks the diagnostic window period, the time between when you are actually infected and when a test can pick it up.

The Diagnostic Window: Why Timing Matters

After HIV enters your body, the virus goes through a predictable sequence of becoming detectable by different tests. Understanding this sequence helps you interpret your result, especially if you are testing soon after a potential exposure.

A study of 222 seroconversion specimens found that the interval between infection and test reactivity is shortest for RNA-based tests and longest for older antibody formats, with fourth-generation lab-based Ag/Ab assays falling in between. If you are testing within the first month after a potential exposure, a lab-based fourth-generation test is far more reliable than a rapid point-of-care test for ruling out very early infection.

How Accurate Is This Test?

The accuracy of an HIV test depends on two things: how well it catches true infections (sensitivity) and how well it avoids calling uninfected people positive (specificity). Lab-based fourth-generation Ag/Ab combo tests perform extremely well on both counts for established infection, but the picture is more nuanced for very early (acute) infection and for rapid point-of-care formats.

Sources: Guiraud 2024 (Access combo V2, n=1,373); Peters 2016 (lab combo, n=86,836); Hecht 2002 (p24 alone, n=258); Parker 2018 and Faraoni 2013 (Determine rapid); Lewis 2015 (systematic review of rapid tests).

What this means for you: if you get a non-reactive result on a lab-based fourth-generation test at least 45 days after your last possible exposure, you can be very confident the result is accurate. If you are testing within the first few weeks after exposure, a non-reactive result is reassuring but does not completely rule out a very recent infection. In that scenario, retesting two to four weeks later or requesting an HIV RNA test provides greater certainty.

The Problem with Rapid Tests and Early Infection

Rapid point-of-care HIV tests that claim to detect both antigen and antibody are convenient, but their p24 antigen component performs poorly in real-world conditions. A systematic review found that the antigen sensitivity of fourth-generation rapid tests in the field was as low as 0%, meaning they missed nearly all acute infections that lacked antibodies. A study of over 12,900 men who have sex with men in a community testing center found that rapid fourth-generation tests did detect some acute cases, but lab confirmation was still required.

If you suspect a recent exposure, a rapid test alone is not enough to rule out acute HIV. A lab-based fourth-generation test or an HIV RNA test is the appropriate choice.

What a Reactive Result Means for Disease Progression

If your test comes back reactive and confirmatory testing confirms HIV infection, the p24 antigen level can indicate how fast the infection may progress. Higher p24 levels in the blood correlate with faster loss of CD4 T cells (the immune cells HIV targets), faster progression to AIDS, and shorter survival in the absence of treatment. In a study of 169 adults followed over several years, p24 concentration predicted CD4 decline and progression to AIDS as well as, or in some comparisons better than, viral RNA measurement.

Among 96 hemophilia patients with HIV tracked in the late 1980s, those with persistent p24 in their blood had significantly worse outcomes than those who cleared it. And in infants born to HIV-positive mothers, persistent high p24 levels in the first months of life signaled a poor prognosis and reduced survival.

Once antiretroviral therapy (ART) is started, p24 levels typically fall rapidly toward undetectable. In a study of 55 patients on long-term suppressive ART, those with any lingering p24 had smaller gains in CD4 cell counts and higher markers of ongoing immune activation compared to those with fully undetectable p24. A 2025 study of 149 people on suppressive ART found that ultra-low levels of p24, detectable only by the most sensitive lab methods, were associated with persistent activation and exhaustion of immune cells, even when standard viral load testing showed the virus was fully suppressed.

When Results Can Be Misleading

A reactive result on a fourth-generation screening test does not automatically mean you have HIV. In populations where HIV is uncommon, false-positive results happen. A study of over 12,300 specimens in a low-prevalence US population found a low but measurable rate of false-positive Ag/Ab results, most of which were resolved as negative by confirmatory testing. In low-prevalence UK community and sexual health clinics, fourth-generation rapid tests produced more false positives than third-generation antibody-only tests without meaningfully improving detection of true positives.

A case report documented that SARS-CoV-2 infection caused a false-reactive HIV result on an automated lab screening test, resolved as negative by Western blot and undetectable viral load. This is rare, but it means that any reactive screening result must be confirmed before it is considered a diagnosis.

• False positives in low-risk populations: the lower your actual chance of having HIV, the more likely a reactive screening result is a false alarm. Confirmatory testing is always required.
• Testing too soon after exposure: a non-reactive result within the first two weeks after exposure does not rule out infection. The virus may not yet have produced enough p24 to detect.
• Rapid test limitations: rapid combo tests often miss the p24 window entirely. A negative rapid test after recent exposure should be followed by a lab-based test.
• Antibody formation masking antigen: as your body makes anti-p24 antibodies, they bind to free p24 and can make it undetectable on some assays, even though the virus is still present. This is why combo tests look for both antigen and antibody.

Why Repeat Testing Matters

For screening purposes, a single non-reactive result on a lab-based fourth-generation test taken at least 45 days after your last possible exposure is highly reliable. But if you have ongoing risk factors, a single test only tells you your status at that moment. The CDC recommends at least annual screening for anyone at increased risk, including men who have sex with men, people who inject drugs, and anyone with a new sexual partner whose status is unknown.

If you are in a higher-risk category, testing every three to six months is reasonable and gives you the best chance of catching an infection early. People taking PrEP (pre-exposure prophylaxis) are typically tested every three months as part of their ongoing care. For anyone focused on prevention, knowing your status quarterly means that if infection does occur, it is caught in its earliest, most treatable phase.

For people already diagnosed with HIV and on treatment, p24 is not the routine monitoring tool. Standard viral load (HIV RNA) and CD4 counts are used instead. However, research-grade ultrasensitive p24 assays may become useful in the future for assessing how deeply ART has suppressed viral protein production, a question relevant to cure research.

What to Do With Your Result

If your test is non-reactive and you are outside the window period (at least 45 days since your last possible exposure for a lab-based test), your result is reliable. If you have ongoing risk, schedule your next screening in three to six months.

If your test is reactive, the lab will automatically run confirmatory testing, usually an HIV-1/HIV-2 antibody differentiation assay. If that is also positive, the diagnosis is confirmed. If the confirmatory test is negative or indeterminate, an HIV-1 RNA test resolves the question. A study of over 504,000 routine test results across six US laboratories found that the confirmatory assay had a 99.4% positive predictive value for HIV-1, meaning nearly all confirmed positives were true infections.

If HIV infection is confirmed, the next steps are straightforward: connect with an infectious disease specialist or HIV care provider, get baseline CD4 count and viral load testing, and begin antiretroviral therapy as soon as possible. Early treatment preserves immune function and reduces the amount of virus that embeds itself in long-lived cells. It also reduces the risk of transmitting HIV to others to effectively zero when the virus is fully suppressed.

If your result is indeterminate or if you tested during the window period, do not assume the worst or the best. Retest in two to four weeks with a lab-based test or request an HIV RNA test for the fastest answer.